|
Associate Dean and Professor, Dept. of Biochemistry and Molecular Biology, USC Keck School of Medicine
World's foremost authority on therapeutic compounds from snake venom. With over 120 published articles, a clinical trial based on his novel compound from snake venom to treat blood clots is under way at Nuvelo, Inc.
Pivotal's Scientific and Business Advisory Board consists of highly respected individuals in their scientific fields who provide an invaluable resource to Pivotal through the R&D process. Their collective experience includes domain expertise in the development and testing of new therapies for cancer, immunotherapy and vaccine development, infectious diseases, pharmacology, biophysics and structural biology at the USC Keck School of Medicine, M.D. Anderson Cancer Center/University of Texas, and The Mayo Clinic. | 